Literature DB >> 28265218

Minimally Invasive LVAD Deactivation in a 65-Year-Old Man with Recurrent Pump Thrombosis and Left Ventricular Recovery.

Akshay Pendyal, Christopher V Chien, James O Mudd, Jill M Gelow.   

Abstract

Pump thrombosis is a dire sequela after left ventricular assist device (LVAD) implantation. Treatment comprises antiplatelet agents, anticoagulants, thrombolytic agents, and pump exchange. Although pump exchange is the definitive therapy, it is also the most invasive, often exposing patients to the risks of repeat sternotomy and cardiopulmonary bypass. In some cases, patients experience left ventricular recovery after LVAD implantation. The optimal strategy surrounding the management of LVADs in patients who have experienced ventricular recovery is unknown; techniques range from total system explantation to partial pump resection. Here, we describe a novel means of LVAD deactivation in a 65-year-old man with recurrent pump thrombosis, via percutaneous outflow graft closure in the cardiac catheterization laboratory. We also review the existing literature on surgical and percutaneous LVAD deactivation techniques.

Entities:  

Keywords:  Device removal/instrumentation/methods; heart failure/rehabilitation; heart-assist devices/adverse effects; recovery of function/physiology; thrombosis/etiology; treatment outcome; ventricular function/physiology

Mesh:

Year:  2017        PMID: 28265218      PMCID: PMC5317366          DOI: 10.14503/THIJ-16-5787

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  13 in total

1.  A felt plug simplifies left ventricular assist device removal after successful bridge to recovery.

Authors:  William E Cohn; Igor D Gregoric; Branislav Radovancevic; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

2.  Percutaneous withdrawal of HeartWare HVAD left ventricular assist device support.

Authors:  Stephen J Pettit; Leonard M Shapiro; Clive Lewis; Jayan K Parameshwar; Steven S L Tsui
Journal:  J Heart Lung Transplant       Date:  2015-02-12       Impact factor: 10.247

3.  Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function.

Authors:  David J Farrar; William R Holman; Lawrence R McBride; Robert L Kormos; Timothy B Icenogle; Paul J Hendry; Charles H Moore; Daniel Y Loisance; Aly El-Banayosy; Howard Frazier
Journal:  J Heart Lung Transplant       Date:  2002-05       Impact factor: 10.247

4.  Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.

Authors:  O H Frazier; Andrew C W Baldwin; Zumrut T Demirozu; Ana Maria Segura; Ruben Hernandez; Heinrich Taegtmeyer; Hari Mallidi; William E Cohn
Journal:  J Heart Lung Transplant       Date:  2014-09-28       Impact factor: 10.247

Review 5.  Medication management for left ventricular assist device thrombosis.

Authors:  Elizabeth Hohner; Jessica Crow; Michael P Moranville
Journal:  Am J Health Syst Pharm       Date:  2015-07-01       Impact factor: 2.637

6.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

7.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

8.  Left ventricular assist device and drug therapy for the reversal of heart failure.

Authors:  Emma J Birks; Patrick D Tansley; James Hardy; Robert S George; Christopher T Bowles; Margaret Burke; Nicholas R Banner; Asghar Khaghani; Magdi H Yacoub
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

9.  Advanced heart failure treated with continuous-flow left ventricular assist device.

Authors:  Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier
Journal:  N Engl J Med       Date:  2009-11-17       Impact factor: 91.245

10.  A novel, catheter-based approach to left ventricular assist device deactivation after myocardial recovery.

Authors:  Sanford M Zeigler; Ahmad Y Sheikh; Peter H U Lee; Jay Desai; Dipanjan Banerjee; Philip Oyer; Michael D Dake; Richard V Ha
Journal:  Ann Thorac Surg       Date:  2014-08       Impact factor: 4.330

View more
  2 in total

1.  Percutaneous Decommissioning of a Left Ventricular Assist Device in a Patient With Myocardial Recovery.

Authors:  Pankaj Jain; Michael S Kiernan; Gregory S Couper; Ethan Y Brovman; Samantha R Asber; Carey Kimmelstiel
Journal:  JACC Case Rep       Date:  2022-03-16

2.  Percutaneous approach to left ventricular assist device decommissioning.

Authors:  Francesco Moroni; Keyur B Shah; Mohammed A Quader; Katherine Klein; Melissa C Smallfield; Kendall E Parris; Zachary M Gertz
Journal:  Catheter Cardiovasc Interv       Date:  2022-05-17       Impact factor: 2.585

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.